Highlights:
• Metallurgical viability confirmed: Initial metallurgical test work confirms the feasibility of
employing acid leaching to beneficiate copper mineralisation discovered at the Ngami Copper
Project (NCP);
• Hydrogeological insights: Detailed review of the hydrogeology, including fracture distribution
logging and numerical modelling, demonstrates the laterally extensive mineralisation at NCP
satisfies key criteria required for In-Situ Copper Recovery (ISCR);
• Innovative cost-effective prospect: ISCR, if successful, provides an economically efficient
method for developing several tens of kilometres strike of moderate-grade copper mineralisation
at NCP, with minimal environmental impact and requiring low initial capital and operating
expenditures;
• Following the success of the first phase of metallurgical test work, where copper recovery rates
of 55.7% and 45.4% were achieved from moderate and high-grade composite samples
respectively, Cobre has initiated additional testing to optimise leaching conditions to further
increase copper recoveries;
• Further hydrogeological test work designed to prove the viability of ISCR will include a series of
pumping tests to provide an estimate of hydraulic conductivity and connectivity along the fracture
zones associated with mineralisation; and
• Release of Inferred Resource and Exploration Target Category modelling results, expected within
Q3 2023, will provide further insight into the project’s scale and potential avenues for expansion
at NCP.
- Forums
- ASX - By Stock
- Ann: Potential for Extensive In-Situ Copper Mining - Botswana
Highlights:• Metallurgical viability confirmed: Initial...
Featured News
Add CBE (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.6¢ |
Change
0.002(3.70%) |
Mkt cap ! $23.93M |
Open | High | Low | Value | Volume |
5.4¢ | 5.7¢ | 5.4¢ | $77.87K | 1.398M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 565000 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 120000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 515000 | 0.055 |
1 | 102045 | 0.054 |
2 | 156081 | 0.053 |
2 | 350000 | 0.052 |
4 | 133403 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 50000 | 1 |
0.059 | 100000 | 1 |
0.061 | 140000 | 1 |
0.062 | 135000 | 1 |
0.063 | 150000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
CBE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online